SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-032935
Filing Date
2020-05-29
Accepted
2020-05-29 16:30:10
Documents
2
Period of Report
2020-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 POA DOCUMENT poa.txt EX-24.3_918531 3773
  Complete submission text file 0001209191-20-032935.txt   6871
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address 919-678-6611
Collard Craig A (Reporting) CIK: 0001363558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 20928370